WuXi Biologics CEO: Vaccine CDMO is the next area of growth

Dr Chris Chen launches WuXi Vaccines, announces new facility and a 20-year manufacturing contract worth US$3 billion

picture of

Breaking News

Sofie promotes theranostics with new Center of Excellence

IPS-Integrated Project Services will build four cleanrooms as part of the 30,000 sqft facility with another room that ...

Glenmark chooses Novartis for respiratory products

The Seebri, Onbrize and Ultibro products are indicated for COPD symptoms and will be manufactured by Novartis for ...

Parexel and CluePoints join forces

Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance data quality ...

Small molecule CDMOs reacting to changing market demands

The pharmaceutical industry continues to evolve in two interesting ways: first, the development pipeline sees a variety ...

Axovant Gene Therapies chooses Yposkesi for viral vector production

The initial focus of the agreement will be on AAV-based gene therapies

Gamida extends Lonza partnership beyond clinical to commercial

Agreement is in preparation for potential FDA approval of Gamida’s cell therapy candidate

CMC strategies for the acceleration of commercial-ready ADC manufacturing

The potential for antibody-drug conjugate (ADC) programmes to accelerate from early to late stage clinical development ...

EnteroBiotix secures MHRA license for clinical trial manufacturing

The Scottish microbiome specialists is also working on creating a common European regulatory framework for microbiome ...

Concept Life Sciences opens new niche API facility

UK-based company now offers services from development to cGMP-compliant production

The Manufacturing Chemist outsourcing roundtable: part I

Discussing the upcoming and ongoing trends in the contract pharmaceutical sector, Dr Kevin Robinson recently caught up ...

The Manufacturing Chemist outsourcing roundtable: part II

Having talked about upcoming trends, potential growth and in-demand services in Part I, I open the second session by ...

CDMO market trends and dynamics

The rise of the embedded model

Iveric Bio chooses Catalent for AAV vector manufacturing

Vectors are for preclinical uses in retinal disease gene therapy candidates

NanoComposix enters drug CMO market

The nanomaterial producer has expanded capabilities to include drug manufacture as it receives drug manufacturing ...